---
title: "PASG.US (PASG.US) — Related News"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/PASG.US/news.md"
symbol: "PASG.US"
name: "PASG.US"
parent: "https://longbridge.com/en/quote/PASG.US.md"
datetime: "2026-05-21T21:41:20.631Z"
locales:
  - [en](https://longbridge.com/en/quote/PASG.US/news.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/PASG.US/news.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/PASG.US/news.md)
---

# PASG.US (PASG.US) — Related News

### [Passage Bio | 10-Q: FY2026 Q1 Revenue: USD 0](https://longbridge.com/en/news/286085454.md)
*2026-05-12T11:03:42.000Z*
### [This Mohawk Industries Analyst Is No Longer Bullish; Here Are Top 2 Downgrades For Tuesday](https://longbridge.com/en/news/283521314.md)
*2026-04-21T14:30:18.000Z*
> Wall Street analysts have downgraded Mohawk Industries from Outperform to Neutral, reducing the price target from $156 t

### [Buy Rating Reaffirmed on Encouraging upliFT-D Biomarker Data and Solid Cash Runway Supporting Expanded FTD-GRN Trial](https://longbridge.com/en/news/283493626.md)
*2026-04-21T11:45:22.000Z*
> Analyst Yun Zhong of Wedbush reaffirmed a Buy rating on Passage Bio with a price target of $32.00, citing positive bioma

### [Pre-market hot trades in US stocks: UnitedHealth up 5.73% pre-market; Passage Bio up 5.60% pre-market](https://longbridge.com/en/news/283475504.md)
*2026-04-21T10:03:02.000Z*
> UnitedHealth pre-market up 5.73%; Passage Bio pre-market up 5.60%; Local Bounti pre-market up 61.70%; Baiya pre-market u

### [12 Health Care Stocks Moving In Monday's Intraday Session](https://longbridge.com/en/news/283385887.md)
*2026-04-20T17:05:50.000Z*
> In Monday's intraday session, Enveric Biosciences (ENVB) saw a significant gain of 132.7%, reaching $4.24, while Psyence

### [](https://longbridge.com/en/news/283362156.md)
*2026-04-20T13:02:38.000Z*
> Passage Bio shares are trading lower after the company announced the FDA did not support a single-arm trial design for i

### [Passage Bio reports biomarker improvements, FDA says randomized registrational trial required](https://longbridge.com/en/news/283343631.md)
*2026-04-20T11:23:00.000Z*
> Passage Bio reported interim data from its upliFT-D study, showing significant reductions in brain atrophy and stabiliza